FDMT vs MCD · rev $37.0K vs P/E 23, rev $25.92B
4D Molecular Therapeutics Inc (FDMT) versus McDonald’s Corporation (MCD) — a side-by-side from cached financials, not a winner call.
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
McDonald’s Corporation (MCD) is a restaurants company listed on NYSE. It is led by Chris Kempczinski.
Latest reported FDMT revenue for 2024-12-31 was $37.0K. Net income was -$160.9M. Revenue was down 99.8% from 2023-12-31 to 2024-12-31. FDMT currently screens at market cap $518.1M.
Latest reported MCD revenue for 2024-12-31 was $25.92B. Net income was $8.22B. Revenue was up 1.7% from 2023-12-31 to 2024-12-31. MCD currently screens at market cap $201.66B and trailing P/E 23.4.
FDMT currently screens at market cap $518.1M. MCD currently screens at market cap $201.66B and trailing P/E 23.4.
Not investment advice. Open the FDMT and MCD stock pages for the full models.
Not investment advice.